These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6675772)

  • 21. Neurotoxicological and thyroid evaluations of rats developmentally exposed to tris(1,3-dichloro-2-propyl)phosphate (TDCIPP) and tris(2-chloro-2-ethyl)phosphate (TCEP).
    Moser VC; Phillips PM; Hedge JM; McDaniel KL
    Neurotoxicol Teratol; 2015; 52(Pt B):236-47. PubMed ID: 26300399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotoxicity of the flame retardant tris(2,3-dibromopropyl)phosphate.
    Dybing E; Søderlund E
    Arch Toxicol Suppl; 1980; 4():219-22. PubMed ID: 6933906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites.
    Lynn RK; Garvie-Gould C; Wong K; Kennish JM
    Toxicol Appl Pharmacol; 1982 Mar; 63(1):105-19. PubMed ID: 7071866
    [No Abstract]   [Full Text] [Related]  

  • 24. Subchronic toxicity studies indicate that tris(2-chloroethyl)phosphate administration results in lesions in the rat hippocampus.
    Matthews HB; Dixon D; Herr DW; Tilson H
    Toxicol Ind Health; 1990 Jan; 6(1):1-15. PubMed ID: 2349570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of alternative assays to identify and prioritize organophosphorus flame retardants for potential developmental and neurotoxicity.
    Behl M; Hsieh JH; Shafer TJ; Mundy WR; Rice JR; Boyd WA; Freedman JH; Hunter ES; Jarema KA; Padilla S; Tice RR
    Neurotoxicol Teratol; 2015; 52(Pt B):181-93. PubMed ID: 26386178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantum chemical simulations revealed the toxicokinetic mechanisms of organic phosphorus flame retardants catalyzed by P450 enzymes.
    Fu Z; Chen J; Wang Y; Hong H; Xie H
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2018; 36(4):272-291. PubMed ID: 30457030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tris(2-chloroethyl) phosphate exposure on chicken embryos in a shell-less incubation system.
    Kanda K; Ito S; Koh DH; Kim EY; Iwata H
    Ecotoxicol Environ Saf; 2021 Jan; 207():111263. PubMed ID: 32916532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ORGANOPHOSPHORUS FLAME RETARDANTS - TOXICITY AND INFLUENCE ON HUMAN HEALTH].
    Bruchajzer E; Frydrych B; Szymańska JA
    Med Pr; 2015; 66(2):235-64. PubMed ID: 26294315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity and nephrotoxicity of two tris (2,3-dibromopropyl)-phosphate analogues: bis (2,3-dibromopropyl) phosphate and 2,3-dibromopropylphosphate.
    Søderlund E; Nelson SD; Dybing E
    Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):76-80. PubMed ID: 7124413
    [No Abstract]   [Full Text] [Related]  

  • 30. A new mutagenic and genotoxic response of the flame retardant tris(2,3-dibromopropyl)phosphate. Activation by singlet oxygen.
    McCoy E; Hyman J; Rosenkranz HS
    Mutat Res; 1980 Mar; 77(3):209-14. PubMed ID: 6991918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing in-vitro estrogenic effects of currently-used flame retardants.
    Krivoshiev BV; Dardenne F; Covaci A; Blust R; Husson SJ
    Toxicol In Vitro; 2016 Jun; 33():153-62. PubMed ID: 26979758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity studies on the mutagenicity of tris(2,3-dibromopropyl) phosphate (Tris-BP) and its metabolites in Salmonella.
    Zeiger E; Pagano DA; Nomeir AA
    Environ Mutagen; 1982; 4(3):271-7. PubMed ID: 7094911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tris(2,3-dibromopropyl) phosphate.
    National Toxicology Program
    Rep Carcinog; 2011; 12():428-9. PubMed ID: 21863116
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of tris (2,3-dibromopropyl) phosphate on the prenatal and postnatal developments of the rats (author's transl)].
    Kawashima K; Tanaka S; Nakaura S; Nagao S; Onoda K; Kasuya Y; Omori Y
    Eisei Shikenjo Hokoku; 1980; 98():50-5. PubMed ID: 7248626
    [No Abstract]   [Full Text] [Related]  

  • 35. Tris(2,3-dibromopropyl) phosphate.
    Rep Carcinog; 2004; 11():III84-5. PubMed ID: 21105245
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic activation of bromopropyl compounds.
    Dybing E; Söderlund EJ; Nelson SD
    Adv Exp Med Biol; 1981; 136 Pt A():647-54. PubMed ID: 7046380
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxicity, absorption and elimination of phosphoric acid triesters by killifish and goldfish.
    Sasaki K; Takeda M; Uchiyama M
    Bull Environ Contam Toxicol; 1981 Dec; 27(6):775-82. PubMed ID: 7337849
    [No Abstract]   [Full Text] [Related]  

  • 38. Tris(2,3-dibromopropyl) phosphate.
    National Toxicology Program
    Rep Carcinog; 2002; 10():83-4. PubMed ID: 15323032
    [No Abstract]   [Full Text] [Related]  

  • 39. Organophosphorus flame retardants in the European eel in Flanders, Belgium: Occurrence, fate and human health risk.
    Malarvannan G; Belpaire C; Geeraerts C; Eulaers I; Neels H; Covaci A
    Environ Res; 2015 Jul; 140():604-10. PubMed ID: 26056994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotoxicity and risk assessment of brominated and alternative flame retardants.
    Hendriks HS; Westerink RH
    Neurotoxicol Teratol; 2015; 52(Pt B):248-69. PubMed ID: 26363216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.